0000885590-15-000019.txt : 20150304
0000885590-15-000019.hdr.sgml : 20150304
20150304172430
ACCESSION NUMBER: 0000885590-15-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150302
FILED AS OF DATE: 20150304
DATE AS OF CHANGE: 20150304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chai-Onn Robert Roswell
CENTRAL INDEX KEY: 0001502213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 15674497
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-03-02
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001502213
Chai-Onn Robert Roswell
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, CLO, General Counsel
Common Stock, no par value
2015-03-02
4
M
0
90939
25.42
A
112296
D
Common Stock, no par value
2015-03-02
4
S
0
90939
200.0142
D
21379
D
Common Stock, no par value
2015-03-03
4
M
0
21808
6.1
A
43187
D
Non-Qualified Stock Options (right to purchase)
25.42
2015-03-02
4
M
0
90939
0
D
2014-10-08
2015-11-11
Common shares, no par value
90939
90938
D
Non-Qualified Stock Options (right to purchase)
6.1
2015-03-03
4
M
0
21808
0
D
2009-11-01
2015-11-01
Common shares, no par value
21808
21807
D
This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 11, 2015.
This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold, in each case pursuant to a 10b5-1 trading plan. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
This number represents options exercised and held pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 1, 2015.
The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the vesting commencement date, the second vest date falling on the second anniversary of the vesting commencement date, the third vest date falling on the third anniversary of the vesting commencement date, and the fourth vest date falling on the fourth anniversary of the vesting commencement date.
by: Nicholas Zanoni for Robert Chai-Onn
2015-03-04